(Q36066068)

12 August 2017

1 reference

title

Treatment strategies underpinning the global programme to eliminate lymphatic filariasis (English)

1 reference

12 August 2017

0 references

John O Gyapong

1

1 reference

12 August 2017

Vasanthapuram Kumaraswami

series ordinal

2

1 reference

12 August 2017

Gautam Biswas

series ordinal

3

1 reference

12 August 2017

Eric A Ottesen

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

179-200

1 reference

Social and economic factors and the control of lymphatic filariasis: a review

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Immunological aspects of lymphatic filariasis and onchocerciasis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Rapid community diagnosis of lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Prevalence of hydrocele as a rapid diagnostic index for lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The relationship between infection and disease in Wuchereria bancrofti infection in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The role of albendazole in programmes to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Ivermectin in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Assessing the risk of benzimidazole therapy during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a ho

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Mass treatment to eliminate filariasis in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The efficacy, tolerability and safety of diethylcarbamazine-fortified salt in the treatment of the microfilaraemias of brugian filariasis: an open, hospital-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Controlling onchocerciasis by community-directed, ivermectin-treatment programmes in Uganda: why do some communities succeed and others fail?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Community-directed treatment: The way forward to eliminating lymphatic filariasis as a public-health problem in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Single-dose treatment of wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: Evaluation of the potential for control at 12 months after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Long-lasting reduction of Brugia timori microfilariae following a single dose of diethylcarbamazine combined with albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Optimising the benefits of anthelmintic treatment in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Genetic variability following selection of Haemonchus contortus with anthelmintics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

The genetics of ivermectin resistance in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

Tropical Pulmonary Eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.179

21 January 2018

Identifiers

DOI

10.1517/14656566.6.2.179

1 reference

release_5ms5sxr5tjcmjbdgi7ga7edte4

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5ms5sxr5tjcmjbdgi7ga7edte4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference